Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?

by Miranda van Berkel, Matthijs Kox, Tim Frenzel, Peter Pickkers, Jeroen Schouten, on behalf of the RCI-COVID-19 study group
Published 2020-10-01

Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients

by Emma J. Kooistra, Miranda van Berkel, Noortje F. van Kempen, Celine R. M. van Latum, Niklas Bruse, Tim Frenzel, Maarten J. W. van den Berg, Jeroen A. Schouten, Matthijs Kox, Peter Pickkers
Published 2021-08-01